Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accumulated Expenses (2022 - 2024)

Historic Accumulated Expenses for Lucid Diagnostics (LUCD) over the last 3 years, with Q4 2024 value amounting to $1.5 million.

  • Lucid Diagnostics' Accumulated Expenses rose 2555.18% to $1.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year increase of 2555.18%. This contributed to the annual value of $1.5 million for FY2024, which is 2555.18% up from last year.
  • Per Lucid Diagnostics' latest filing, its Accumulated Expenses stood at $1.5 million for Q4 2024, which was up 2555.18% from $1.2 million recorded in Q4 2023.
  • In the past 5 years, Lucid Diagnostics' Accumulated Expenses ranged from a high of $2.2 million in Q1 2022 and a low of $879000.0 during Q4 2022
  • Its 3-year average for Accumulated Expenses is $1.4 million, with a median of $1.2 million in 2022.
  • In the last 5 years, Lucid Diagnostics' Accumulated Expenses surged by 3401.59% in 2023 and then skyrocketed by 2555.18% in 2024.
  • Quarter analysis of 3 years shows Lucid Diagnostics' Accumulated Expenses stood at $879000.0 in 2022, then skyrocketed by 34.02% to $1.2 million in 2023, then increased by 25.55% to $1.5 million in 2024.
  • Its Accumulated Expenses was $1.5 million in Q4 2024, compared to $1.2 million in Q4 2023 and $879000.0 in Q4 2022.